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Considering that the dosage of manipulating Moxa plays an important role in obtaining good eﬀects for heat-sensitive
moxibustion, it would be valuable to know whether the use of ﬁxed dosage is as eﬀective as the use of an individual one. The paper
carried out a rigorous multi-centre randomized controlled trial, and its result demonstrated that the eﬀectiveness of individual
eliminate-sensitive dosing regimen might more superior to the stable conventional dosing regimen in the treatment of KOA.
According the record of individual moxibustion time, the dosage diﬀered in the terms of patients’ conditions and moxibustion
sensation, which had been measured about 47.30 ±6.20 minutes (28 ∼ 65 minutes).
1.Background
Suspended moxibustion is a traditional Chinese medical
intervention that involves the burning of moxa indirectly
at the acupoints. Moxibustion has anti-inﬂammatory or
immunomodulatory eﬀects against chronic inﬂammatory
conditions in humans [1]. Heat-sensitive moxibustion ther-
apy is one of common suspended moxibustion treatments in
China [2]. A great deal of physicians utilized heat-sensitive
moxibustion therapy in diﬀerent kinds of diseases in China.
Moreover, several articles and research reports have reported
the eﬀectiveness and safety of heat-sensitive moxibustion for
KOA [3–8].
Moxibustion uses heat stimulation at various tempera-
ture levels from mild skin warming to tissue damage from
burning. Therefore, the dose of manipulating Moxa plays
an important role in obtaining good eﬀects. The regimen of
moxibustion used for treatment of KOA has varied between
studies.
To sum up, two main regimens were carried out in
these papers. One selected the stable conventional dose,
which was recommended by the universal text book [1].
The therapy was executed for 15 minutes per acupoint.
The other one held that the dose diﬀered in the terms of
patients’ conditions and moxibustion sensation. Treatment
sessions should be ended when patients felt the acupoint
heat-sensitization phenomenon disappeared. We called it
individual eliminate-sensitive dose. Therefore, it would be
valuable to know whether there is diﬀerence between the
eﬀects of two-dose stimulation for KOA in the treatment
of heat-sensitive moxibustion. We planned the rigorous
multicentre randomized controlled trial, in order to seek for
optimal dose of the best therapeutic eﬀect.
2. Methods
2.1. Objective. The aim of this study is to compare the
eﬀectiveness of an individual eliminate-sensitive dose and a2 Evidence-Based Complementary and Alternative Medicine
stable conventional dose in the treatment of patients with
moderate to severe swelling KOA in China.
2.2. Sample Size. The sample size for testing the diﬀerence
between means was calculated with the SPSS 13.0 pro-
gramme, by setting the standard deviation of the guiding
principle of clinical research on new drugs in the treatment
of KOA (GPCRND-KOA) [9] score of 2.55 and 3.39 [5, 6]
and mean diﬀerence of total GPCRND-KOA score between
groups of 2.50, power of 0.9, and a level of signiﬁcance
at 0.05. Allowing for a 20% loss to follow up, a total
of 36 participants were required in each group, with 72
participants in total.
2.3. Design. A multicentre (four centers in China), random-
ized, and assessor blinded, controlled trial was conducted at
the Aﬃliated Hospital with Jiangxi University of Traditional
Chinese Medicine (TCM) in Nanchang, The ﬁrst Aﬃliated
Hospital with Anhui University of TCM in Hefei, Jiangsu
TCM Hospital in Nanjing, and Shanxi TCM Hospital in
Xian. The study was sequentially conducted as follows:
a run-in period of one week prior to randomization, a
treatment period of 30 days, and a follow-up period of
six months. At the end of the run-in period, participants
were randomized to the individual eliminate-sensitive dose
group or the stable conventional dose group by the central
randomization system. This system was provided by China
Academy of Chinese Medical Sciences, which adopted the
computer telephone integration (CTI) technology to inte-
grate computer, internet, and telecom. The random number
list was assigned by interactive voice response (IVR) and
interactive web response (IWR) [10]. The success of blinding
was assessed at each participant’s last visit. Data collection
staﬀ, and data analysts were blinded to treatment group.
2.4. Participants
2.4.1. Recruitment. A total of 72 eligible patients were
enrolledinthestudybetweenDecember30,2009,andMarch
18, 2010, from this multisite. The ethics committees of the
Aﬃliated Hospital with Jiangxi University of TCM approved
the study.
2.4.2. Inclusion Criteria. Eligible participants were those
previously diagnosed with moderate to severe swelling KOA,
according to the GPCRND-KOA criteria (>5s c o r e ) .P a t i e n t s
were required to complete the baseline KOA diary. Written
informed consent was obtained from each participant.
The inclusion criteria restricted the following conditions.
According with the below KOA diagnosis standard, mean-
while, knee joints appeared swell; Floating patella test was
negative; patients accepted the treatment protocol in this
trial; acupoint heat-sensitization phenomenon existed in the
region consisting of Yin Lingquan (SP9), Yang Lingquan
(GB34), Liang Qiu (ST34), and Xue Hai (SP10). Patients
had been stopped receiving previous intervention before
recruitment for two weeks.
2.4.3. Exclusion Criteria. Participants were excluded if they
suﬀer from serious life-threatening disease, such as dis-
ease of the heart and brain blood vessels, liver, kidney,
and hematopoietic system, and psychotic patients. We
excluded patients with diabetes, diabetic polyneuropathy,
and polyneuropathic disturbances. Participants were not
being eligible if the females are in the duration of pregnancy
or lactation. The following conditions were also excluded
items: acute knee joint trauma or ulceration in its local
skin, complicated with serious genu varus/valgus and ﬂexion
contraction.
2.5. Study Interventions. Qualiﬁed specialists of acupuncture
in TCM with at least ﬁve years of clinical experience per-
formedthemoxibustioninthisstudy.Alltreatmentregimens
were standardized between four centers practitioners via
video, hands-on training, and internet workshops. Both
groups of patients were requested not to receive other
treatments including any physical therapies, any pain-killing
medicines, and acupuncture treatment from another place.
In the two groups, 22mm (diameter) × 120mm (length)
moxa-sticks (Jiangxi TCM Hospital, China) were used. The
patient was usually in the comfortable supine position for
treatment, with 24◦C∼30◦C temperature in the room. He
should be wearing loose trousers, especially making his knee
joints exposed.
2.5.1. The Individual Eliminate-Sensitive Dose Group. For
the group, the moxa-sticks were lit by the therapist and
held over the region consisting of Yin Lingquan (SP9), Yang
Lingquan (GB34), Liang Qiu (ST34), and Xue Hai (SP10).
The warming suspended moxibustion lied 3cm far from
the surface of skin was used to search the acupoint heat-
sensitization phenomenon. The areas were brought mild
warmth without burning by moxa-sticks and manipulated
untilthepatientreportedthecharacteristicheatsensitization
sensation, said to indicate eﬀective moxibustion, that is
commonly called De Qi. Patients felt comfortable in the
moxibustion manipulation.
The following patients sensation suggested the special
heat sensitization acupoint: diathermanous sensation due to
moxa-heat, deﬁning as the heat sensation conducting from
the moxa local skin surface into deep tissue, or even into
the joint cavity; expand heat sensation due to moxa-heat,
deﬁning as the heat sensation spreading the surrounding
little by little around the moxa point; transfer heat sensation
due to moxa-heat, deﬁning as the heat sensation transferring
along some pathway or direction, even to the ankle or
hip conduction. When some acupoint existed one below
sensation at least, the therapists marked the point as heat-
sensitive acupoint. We tried our best to seek all the special
acupoints in each patient by the repeated manipulation.
After obtaining the heat sensitization sensation, the
therapists began to treat patient’s at these heat-sensitive
acupoints. There was a therapist working on the patient for
the whole time of moxibustion. For moxibustion manipula-
tion, the intensity of the given stimulation was varied with
heat-sensitive sensation. Treatment sessions ended whenEvidence-Based Complementary and Alternative Medicine 3
patients felt the acupoint heat-sensitization phenomenon
disappeared.
In the course of manipulation, the therapist recorded the
time length of every patient from the beginning to the end
in per treatment session. Patients received the treatment two
times/day in the 1st week (one time/day from the 2nd week)
for a total of 35 sessions over 30 days.
2.5.2. The Stable Conventional Dose Group. Common prac-
tices were similar with the ﬁrst group. Only one diﬀerence
was that patients in this group received the identical dose (15
minutes).
2.6. Outcome Measures. Ministry of Health of the People’s
Republic of China (MHPRC) has proposed the guiding
principle of clinical research on new drugs (GPCRND) [9].
In this criteria, a patient with KOA was assessed including
pain, the relation between activity and pain, function
impairment, and special exams. This scoring system was
previously validated. The degree of KOA is divided into three
levels: mild—<5 scores; moderate—5∼9 scores; severe—>9
scores. In the terms of swelling knee, knee circumference was
assessed at each time point. The parameter was measured in
centimeters across the middle of a patella, with ordinary tape
measure [11].
Therapeutic eﬀect was assessed by comparing baseline
and ﬁnal conditions reported by the patient. This trial
also recorded adverse eﬀects reported by patients during
treatment.Theoutcomemeasuresabovewereassessedbefore
the treatment (month 0), at the end of the treatment period
(month 1), and 6 months after the end of the treatment
period (month 7).
2.7. Statistical Methods. We conducted analysis on an
intention-to-treat basis, including all randomized partici-
pants with at least one measurable outcome report. Analyses
will be conducted using 2-sided signiﬁcance tests at the 5%
signiﬁcance level. The statistician conducting the analyses
remained blind to treatment group and data was only
unblended once all data summarized and analyses were
completed. All analyses were conducted in the SAS statistical
package program (ver.9.1.3).
Baseline characteristics were shown as mean standard
deviation (SD) for continuous data including age, previous
duration, and others. As for participants’ gender, n (%)
of male and female in each group were shown as baseline
characteristics. We will consider P<0.05 as statistically
signiﬁcant.
Outcome measures were summarized descriptively
(mean, SD, median, minimum, and maximum) at each time
point by treatment group. The t-test, Mann-Whitney U,
a n dW i l c o x o nt e s tw e r eu s e df o rc o m p a r i s o no fv a r i a b l e s ,
as appropriate. All adverse events reported during the study
were included in the case report forms; the incidence of
adverse events were calculated. Missing data was replaced
according to the principle of the last observation carried
forward.
2.8.AdverseEvents. Wedeﬁnedadverseeventsasunfavorable
or unintended signs, symptoms, or disease occurring after
treatment that were not necessarily related to the moxibus-
tion intervention.
2.9. Ethics. Written consent was obtained from each partici-
pant. The study was conducted by a coordination center at
the Aﬃliated Hospital with Jiangxi University of TCM in
Nanchang and was approved by the Ethics Committee of the
Aﬃliated Hospital of Jiangxi University of TCM.
3. Results
3.1. Recruitment and Baseline. Participants 42∼70 years
of age were recruited from outpatient and inpatient in
four centers. Of 288 screened patients, 216 could not
be included in the study, mainly because they did not
meet all eligibility criteria (Figure 1). Thus, 72 patients
were randomly assigned into 2 treatment groups by 30
investigators. In follow-up visit, two patients dropped out
of the study. One was in the individual eliminate-sensitive
dose: because of falling injury of Legs. One patient in the
stable conventional dose group was lost because of requiring
another treatment in other hospitals. We also questioned
patients about the intake of medication. Of 34 patients
receiving pharmaceutical intervention before recruitment,
20 took NSAIDS such as ibuprofen, and Naprosyn; 14
were treated by glucosamine/chondroitin. There were no
pretreatment diﬀerences among the two treatment groups at
baseline (Table 1).
3.2. Outcome
3.2.1. Total GPCRND-KOA Score. Reductions in mean total
GPCRND-KOA score at months 1 and 7 compared to
baseline were observed and were highly signiﬁcant (P<
0.001 for all comparisons). At both time points, there was
highly signiﬁcant diﬀerence between the groups (P<0.01)
as shown in Table 2. Figure 2 shows that the mean total
GPCRND-KOA score of both groups reduced sharply at the
ﬁrst month then remained decreasing to the end of month 7.
3.2.2. Knee Circumference. Reductions in mean knee cir-
cumference at months 1 and 7 compared to baseline were
observed and were signiﬁcant (P<0.05 for all comparisons).
At both time points, there was signiﬁcant diﬀerence between
the groups (P<0.05) as shown in Table 3. Figure 3 shows
that the mean knee circumference of both groups reduced a
few at the ﬁrst month then remained decreasing to the end of
month 7.
3.3. Moxibustion Time in the Experimental Group. Diﬀerent
from the control group, moxibustion dose was individual in
the experimental group. According the record of individual
moxibustion time, the dose diﬀered in the terms of patients’
conditions and moxibustion sensation, which had been
measured about 28∼65 minutes in the treatment of KOA.4 Evidence-Based Complementary and Alternative Medicine
Table 1: Baseline characteristics of KOA patients.
Individual group Stable group
Age, mean (SD), years 58 (8.03) 59 (6.94)
Age, min-max, years
Age, min-max, years 42∼70 45∼70
Age >60 year n (%) 14 (38.89%) 12 (33.33%)
Sex n (%)
Male 8 (22.22%) 6 (16.67%)
Female 28 (77.78%) 30 (83.33%)
Duration of knee pain n (%)
<5 year 24 (66.67%) 30 (83.33%)
5–10 year 4 (11.11%) 3 (8.33%)
>10 year 8 (22.22%) 3 (8.33%)
BMI, mean (SD), kg/m  23.08 (2.71) 21.52 (2.43)
BMI, min-max, kg/m  15.64∼31.08 14.98∼28.11
GPCRND-KOA grade n (%)
Severe 24 (67%) 21 (58%)
Moderate 12 (33%) 15 (42%)
Knee circumference at baseline(SD), cm 39.32 (3.43) 39.01 (2.41)
GPCRND-KOA score at baseline
Total score mean (SD) 11.22 (3.06) 10.14 (3.00)
Pain or discomfort in night score mean (SD) 1.33 (0.68) 1.25 (0.73)
Morning stiﬀness score mean (SD) 0.97 (0.56) 1.16 (0.51)
Pain or discomfort in walk score mean (SD) 1.67 (0.53) 1.55 (0.64)
Arise from seat score mean (SD) 0.64 (0.49) 0.58 (0.50)
The maximum walk distance score mean (SD) 1.86 (0.90) 1.50 (0.85)
Board standard airstairs score mean (SD) 1.08 (0.55) 1.14 (0.35)
Step down standard airstairs score mean (SD) 1.19 (0.52) 1.05 (0.41)
Squat or bend knees score mean (SD) 1.36 (0.59) 1.17 (0.61)
Walk over rough terrain score mean (SD) 1.06 (0.53) 0.86 (0.42)
Previous treatment (past-half year)
Pharmaceutical intervention 18 (50.00%) 16 (44.00%)
Physiotherapy 7 (19.44%) 8 (22.22%)
Previous acupuncture treatment 2 (5.56%) 3 (8.33%)
BMI: body mass index; GPCRND-KOA: guiding principle of clinical research on new drugs in the treatment of KOA score; SD: standard deviation; KOA: knee
osteoarthritis.
Table 2: Comparison of GPCRND-KOA scores at baseline, end of treatment (month 1), and followup (month 7), together with between-
group statistical test.
Variable
Baseline Month 1 Month 7
Mean SD t-test∗ Mean SD t-test∗ Mean SD t-test∗
Total
Individual group 11.22 3.06 1.51 3.44 1.93 4.51 2.19 1.85 6.31
95% CI = (10.50∼11.94) 95% CI = (2.99∼3.89) 95% CI = (1.76∼2.62)
Stable group 10.14 3.00 6.13 3.01 5.11 2.07
95% CI = (9.44∼10.84) 95% CI = (5.42∼6.84) 95% CI = (4.62∼5.60)
∗t-test of group diﬀerences at time period, using independent t-test. All data are intention to treat. Both groups n = 36. SD: standard deviation; GPCRND-




Enrollment Assessed for eligibility (n = 288)
Excluded (n = 216)
♦ Not meeting inclusion criteria (n = 174)
♦ Declined to participate (n = 30)
♦ Other reasons (n = 14)
Randomized (n = 72)
Allocated to intervention (n = 36)
♦ Received allocated intervention (n = 36)
♦ Did not receive allocated intervention (give
reasons) (n = 0)
Allocated to intervention (n = 36)
♦ Received allocated intervention (n = 36)
♦ Did not receive allocated intervention (give
reasons) (n = 0)
Lost to followup (give reasons) (n = 1)
Discontinued intervention (give reasons) (n = 0)
Lost to followup (give reasons) (n = 1)
Discontinued intervention (give reasons) (n = 0)
Analysed (n = 36)
♦ Excluded from analysis (give reasons) (n = 0)
Analysed (n = 36)
♦ Excluded from analysis (give reasons) (n = 0)
Figure 1: Flow diagram.
The range of mean moxibustion dose was about 47.30±6.20
minutes in the experimental group.
3.4. Safety. No adverse events were reported for the 72
participants.
4. Discussions
The results of our study extended those previous trials
and demonstrated that patients with KOA who received
individual eliminate-sensitive dose had signiﬁcantly less
pain and better function after 1month than did patients
who received stable conventional dose, according the total
GPCRND-KOA score.
After 7 months, exploratory analysis indicated that the
diﬀerences between the two groups were still signiﬁcant. Sig-
niﬁcant diﬀerences were also evident for knee circumference.
The side-eﬀects of heat-sensitive moxibustion were not
observed. Several large surveys have also provided evidence
that moxibustion is a relatively safe treatment [12–14]. To
our knowledge, our study is the largest reported randomized
controlled trial in this regard. Its strengths included inter-
ventions based on expert consensus by qualiﬁed and expe-
rienced medical acupuncturists, outcome measurements as
recommended in guidelines for trials on KOA, and very high
follow-up rates. Our study used central randomization to
ensureadequateconcealmentingroupassignment.However,
one could argue that our results might have been biased
by a lack of suﬃcient blinding. Due to the nature of
the intervention, it was not possible to blind therapists
to treatment. Both the evaluation of the results and the
statistical analysis were carried out in a blind fashion.
Our results lent support to the ﬁndings of two previous
smaller trials, one of which were randomized [5]a n do n e
was not [6]. The diﬀerences in ﬁndings might be due to
low statistical power in the early trials, use of diﬀerent
measurement instruments and a short-term followup.
Traditionally, diﬀerent moxibustion techniques were
used and suspended moxibustion is the main therapy
resultingfromtheburningofmoxaproducestheradiantheat
and drug eﬀects to acupoints. Heat-sensitive moxibustion
is diﬀerent from other conventional suspended moxibustion
treatments. Generally speaking, the conventional suspended
moxibustion manipulates a moxa stick in which the moxa
stick is placed 2-3cm from the skin with the intention
of mildly warming local sites. Facing diﬀerent patients, it
selects a series of identical and ﬁxed acupoints to treat.
And the moxa stick isusually lighted around the acupoints




Baseline Month 1 Month 7
Mean SD t-test∗ Mean SD t-test∗ Mean SD t-test∗
Knee circumference, cm
Individual group 39.32 33.42 0.44 36.21 3.40 2.51 35.81 3.63 2.78
95% CI = (38.52∼40.12) 95% CI = (35.41∼37.01) 95% CI = (34.96∼36.66)
Stable group 39.01 2.41 38.03 2.72 37.92 2.74
95% CI = (38.44∼39.58) 95% CI = (37.39∼38.67) 95% CI = (37.28∼38.56)



































Figure 2: Mean total GPCRND-KOA (ITT, intention to treat
analysis) at each time point.
the skin becomes slightly red. In this traditional mode,
therapists consider that moxibustion can take eﬀect whenthe
patientsfeellocalandsurfaceheatsensation.Timeconsumed
in this regimen is identical length for various patients.
Namely, moxibustion time per acupoint is uniform but not
individual. We believe that the potential clinical eﬃcacy of
moxibustioncannotbeproducedbyconventionalsuspended
moxibustion treatment. A number of evidences proved heat-
sensitive moxibustion were superior to needle acupuncture
and conventional suspended moxibustion in clinical practice
[2]. The reason is that moxibustion dose in heat-sensitive
moxibustion is diﬀerent from that in conventional sus-
pended moxibustion.
Theoretically, three factors have an impact on moxi-
bustion dose, including intensity, area, and time. The two
former factors are routine as a result of the standard size
of moxa stick in practice. Hence, time becomes a variable
parameter and plays a quite important part in moxibustion
dose. We wonder how long the optimum dose should be
obeyed in heat-sensitive moxibustion. The simplest method
refers to the stable 15 minutes, which was recommended by
the universal text book. In the book of Method of Needling






































Figure 3: Mean knee circumference (ITT, intention to treat
analysis) at each time point.
teaching material in moxibustion technique in China [1],
a practitioner should light one end of a moxa stick and
hold it an inch or two away from the skin, usually around
the inserted needles to bring mild warmth to the area
without burning, until the skin becomes slightly red. The
moxibustion is recommended as 15 minutes in this book.
Practitioners use moxa to warm regions and acupuncture
points with the intention of stimulating circulation through
the points and inducing a smoother ﬂow of blood and qi. It
is claimed that moxibustion takes, eﬀect in the body with 15
minutes moxibustion.
In this study, our result supported that the individual
eliminate-sensitive dose was likely to become an optimum
selected regimen in heat-sensitive moxibustion. The amount
of moxibustion per acupoint was not ﬁxed, according to
the patient condition and moxibustion sensation. Treat-
ment sessions ended when patients felt the acupoint heat-
sensitization phenomenon disappeared. Thus, the dose is
individualandﬁtforeverypatient.Itreﬂectstherequirement
from patients’ bodies. We termed it as individual eliminate-
sensitive dose. In our study, the range of mean moixbustion
dose was about 47.30 ± 6.20 minutes in the experimental
group. The maximum length was 65 minutes, while theEvidence-Based Complementary and Alternative Medicine 7
shortestonewas28minutes.Asfarasweknow,thefeasibility
of such a time intensive treatment can be carried out by
normal acupuncture-practitioner’s oﬃce in China. Many
TCM hospitals possessed qualiﬁed specialized moxibustion
technicians. Meanwhile, various moxibustion devices were
used to ﬁx the moxa-sticks and reduced manual labour.
As we all know, KOA is an incurable complaint of
musculoskeletal system disease. The aim of initial design
was to explore a better dose of heat-sensitive moxibustion
in the treatment of KOA. Special theory penetrated in our
thought and design, which is the presupposition and basis
in this trial. In the human nature, there are two states of
acupoints, the stimulated or awake state and the rest state.
When the human body suﬀers form disease, the acupoints
on the surface of the body are stimulated and sensitized.
These sensitized acupoints are changed into rest ones in the
course of treatment. The elimination of heat-sensitization
phenomenon is the indication to examine clinical eﬃcacy.
Our ﬁnal results conﬁrmed the theory involving with heat-
sensitive moxibustion to some extent. We also found an
approach to quantify moxibustion dose individually in
clinical practice.
In a word, the result demonstrated that the eﬀectiveness
of individual eliminate-sensitive dose might be more supe-
rior to the stable conventional dose in the treatment of KOA.
Obviously, only 15 minutes in the moxibustion dose was
very diﬃcult to show and uncover the real clinical eﬀects
of suspend moxibustion therapy. According the record of
individual moxibustion time, the dose diﬀered in the terms
of patients’ conditions and moxibustion sensation, which
had been measured about 28∼65 minutes in the treatment
of KOA. In future, if we can conﬁrm this conclusion in other
diseases. Through more rigorous and scientiﬁc evidences, it
will be helpful to disclose inherent law of moxibustion.
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